Atlas Trials

Neoadjuvant Chemotherapy Response in Metaplastic Carcinoma of Triple Negative Breast Cancer

Clinical trial NCT04549584 · TERMINATED

Trial details

NCT number
NCT04549584
Sponsor
Seoul National University Hospital
Status
TERMINATED
Study type
OBSERVATIONAL
Metaplastic Breast Carcinoma
Start date
2020-10-01
Primary completion
2020-12-16
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.